Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years
Background. Because of the increased risk of surgery, thyroid nodules causing compression signs and/or hyperthyroidism are concerning during pregnancy. Patients and Methods. Six patients with nontoxic cystic, four with nontoxic solid, and three with overt hyperthyroidism caused by toxic nodules were...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/765950 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849306994331090944 |
|---|---|
| author | Tamas Solymosi Zsolt Melczer Istvan Szabolcs Endre V. Nagy Miklos Goth |
| author_facet | Tamas Solymosi Zsolt Melczer Istvan Szabolcs Endre V. Nagy Miklos Goth |
| author_sort | Tamas Solymosi |
| collection | DOAJ |
| description | Background. Because of the increased risk of surgery, thyroid nodules causing compression signs and/or hyperthyroidism are concerning during pregnancy. Patients and Methods. Six patients with nontoxic cystic, four with nontoxic solid, and three with overt hyperthyroidism caused by toxic nodules were treated with percutaneous ethanol injection therapy (PEI). An average of 0.68 mL ethanol per 1 mL nodule volume was administered. Mean number of PEI treatments for patients was 2.9. Success was defined as the shrinkage of the nodule by more than 50% of the pretreatment volume (V0) and the normalization of TSH and FT4 levels. The average V0 was 15.3 mL. Short-term success was measured prior to labor, whereas long-term success was determined during the final follow-up (an average of 6.8 years). Results. The pressure symptoms decreased in all but one patient after PEI and did not worsen until delivery. The PEI was successful in 11 (85%) and 7 (54%) patients at short-term and long-term follow-up, respectively. Three patients underwent repeat PEI which was successful in 2 patients. Conclusions. PEI is a safe tool and seems to have good short-term results in treating selected symptomatic pregnant patients. Long-term success may require repeat PEI. |
| format | Article |
| id | doaj-art-24ee32e320ba49f1b676f10afd2bb66d |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-24ee32e320ba49f1b676f10afd2bb66d2025-08-20T03:54:53ZengWileyInternational Journal of Endocrinology1687-83371687-83452015-01-01201510.1155/2015/765950765950Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 YearsTamas Solymosi0Zsolt Melczer1Istvan Szabolcs2Endre V. Nagy3Miklos Goth4Thyroid Outpatient Department, Bugat Hospital, 6 Fenyves Street, Gyongyos, Matrafured 3232, HungaryDepartment of Obstetrics and Gynecology, Semmelweis University, Üllői Street 78/A, Budapest 1082, HungaryDivision of Endocrinology, Medical Centre of Hungarian Defense Forces, 44 Robert Karoly Avenue, Budapest 1134, HungaryDivision of Endocrinology, Department of Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Square 94, Debrecen 4032, HungaryDivision of Endocrinology, Medical Centre of Hungarian Defense Forces, 44 Robert Karoly Avenue, Budapest 1134, HungaryBackground. Because of the increased risk of surgery, thyroid nodules causing compression signs and/or hyperthyroidism are concerning during pregnancy. Patients and Methods. Six patients with nontoxic cystic, four with nontoxic solid, and three with overt hyperthyroidism caused by toxic nodules were treated with percutaneous ethanol injection therapy (PEI). An average of 0.68 mL ethanol per 1 mL nodule volume was administered. Mean number of PEI treatments for patients was 2.9. Success was defined as the shrinkage of the nodule by more than 50% of the pretreatment volume (V0) and the normalization of TSH and FT4 levels. The average V0 was 15.3 mL. Short-term success was measured prior to labor, whereas long-term success was determined during the final follow-up (an average of 6.8 years). Results. The pressure symptoms decreased in all but one patient after PEI and did not worsen until delivery. The PEI was successful in 11 (85%) and 7 (54%) patients at short-term and long-term follow-up, respectively. Three patients underwent repeat PEI which was successful in 2 patients. Conclusions. PEI is a safe tool and seems to have good short-term results in treating selected symptomatic pregnant patients. Long-term success may require repeat PEI.http://dx.doi.org/10.1155/2015/765950 |
| spellingShingle | Tamas Solymosi Zsolt Melczer Istvan Szabolcs Endre V. Nagy Miklos Goth Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years International Journal of Endocrinology |
| title | Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years |
| title_full | Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years |
| title_fullStr | Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years |
| title_full_unstemmed | Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years |
| title_short | Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years |
| title_sort | percutaneous ethanol sclerotherapy of symptomatic nodules is effective and safe in pregnant women a study of 13 patients with an average follow up of 6 8 years |
| url | http://dx.doi.org/10.1155/2015/765950 |
| work_keys_str_mv | AT tamassolymosi percutaneousethanolsclerotherapyofsymptomaticnodulesiseffectiveandsafeinpregnantwomenastudyof13patientswithanaveragefollowupof68years AT zsoltmelczer percutaneousethanolsclerotherapyofsymptomaticnodulesiseffectiveandsafeinpregnantwomenastudyof13patientswithanaveragefollowupof68years AT istvanszabolcs percutaneousethanolsclerotherapyofsymptomaticnodulesiseffectiveandsafeinpregnantwomenastudyof13patientswithanaveragefollowupof68years AT endrevnagy percutaneousethanolsclerotherapyofsymptomaticnodulesiseffectiveandsafeinpregnantwomenastudyof13patientswithanaveragefollowupof68years AT miklosgoth percutaneousethanolsclerotherapyofsymptomaticnodulesiseffectiveandsafeinpregnantwomenastudyof13patientswithanaveragefollowupof68years |